Mubasher: Midpharma reported a net loss of JOD 1.04 million ($1.46 million) in the second quarter of 2016, against a net profit of JOD 23,330 ($32,830) in the same period last year.
As for the first half of the year, the pharmaceutical and medical supplies company posted a 50.09% year-on-year increase in losses to JOD 2.02 million, according to a bourse filing.
